Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 10/2016

01-10-2016

Guns, Doctors and Public Health

Author: Mitchell D. Feldman, MD, MPhil

Published in: Journal of General Internal Medicine | Issue 10/2016

Login to get access

Excerpt

We are now all too familiar with the script. Another act of senseless gun violence is followed by shock and disbelief, then outrage, and eventually indifference. Until the next one comes along, and the cycle continues. …
Literature
1.
Wintemute GJ. The epidemiology of firearm violence in the twenty-first century United States. Annu Rev Public Health. 2015;36:5–19.CrossRefPubMed
2.
3.
4.
5.
6.
Metadata
Title
Guns, Doctors and Public Health
Author
Mitchell D. Feldman, MD, MPhil
Publication date
01-10-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 10/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3822-z

Other articles of this Issue 10/2016

Journal of General Internal Medicine 10/2016 Go to the issue

Capsule Commentary

Capsule Commentary on Chiu et al. BMI Trajectories as a Harbinger of Pre-Diabetes or Underdiagnosed Diabetes: An 18-Year Retrospective Cohort Study in Taiwan

Healing Arts: Materia Medica

Dressed for the Party

Capsule Commentary

Capsule Commentary on Callon et al., Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

Editorial

Putting the Conversation about Gun Ownership and Safety in Context

Clinical Practice: Clinical Images

Bilateral Nephrocalcinosis in Primary Distal Renal Tubular Acidosis

Original Research

Use of the Physician Orders for Life-Sustaining Treatment among California Nursing Home Residents
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits